Methylenedioxyethylamphetamine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Methylenedioxyethylamphetamine
MDEA.svg
MDEA-3D-vdW.png
Systematic (IUPAC) name
1-(1,3-Benzodioxol-5-yl)-N-ethyl-propan-2-amine
Clinical data
Legal status
  • Schedule I (US)
Identifiers
CAS number 82801-81-8
ATC code ?
PubChem CID 105039
ChemSpider 94775
Chemical data
Formula C12H17NO2 
Mol. mass 207.27 g/mol

Methylenedioxyethylamphetamine (3,4-methylenedioxy-N-ethylamphetamine; MDEA; MDE, "Eve") is a psychedelic and entactogenic drug of the phenethylamine and amphetamine chemical classes.

Like 3,4-methylenedioxyamphetamine (MDA), MDEA acts as a serotonin, norepinephrine, and dopamine releasing agent.[1][2][unreliable source?][3][unreliable source?]

The subjective effects of MDEA are very similar to those of methylenedioxymethamphetamine (MDMA). However, the euphoric and "loved up" feelings associated with MDMA are not as pronounced in comparison. It is said to be stoning in high doses.[3][unreliable source?]

See also[edit]

References[edit]

  1. ^ Freudenmann RW, Spitzer M (2004). "The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA)". CNS Drug Reviews 10 (2): 89–116. PMID 15179441. 
  2. ^ Subjective Differences Between MDE and MDMA
  3. ^ a b Erowid Online Books : "PiHKAL" - #106 MDE

External links[edit]